// App-Quantinova.ai

OA28 : CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis: rationale for a biological target driven basket trial across disease subsets

Researchers

Presenter

  • Enrico De Lorenzis

Principal Investigators

  • Adi Mor

  • Rebecca Ross

  • Stefano Di Donato

  • Revital Aricha

  • Hilit Levi

  • Ilan Vaknin

  • Francesco Del Galdo

Medical Centers

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

Locations

  • Israel

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Scleroderma

Biomarkers

  • C-C Motif Chemokine Ligand 24

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved